Related Experiment Videos
Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin
R A Barthelson1, T Potter, F H Valone
1Department of Medicine, Veterans Administration Medical Center, San Francisco, California 94121.
Abstract:
The capacity to stimulate cytokine release may be important to the long-term effects of platelet-activating factor (PAF), which has a very short half-life. Previous studies have shown that PAF stimulates interleukin 1 (IL-1) release by human monocytes. IL-1 and other cytokines produced in response to PAF may be important to the long-term effects of this short-lived lipid. The THP-1 human monocytic leukemia cell line, was used to study the mechanism by which PAF stimulates IL-1 release. PAF stimulates the release of IL-1 beta activity into THP-1 cell supernatants with a multiphasic dose-response curve very similar to that for monocytes. When THP-1 cells are treated with PAF and LPS in combination, these two stimuli interact synergistically to greatly increase the release of IL-1 activity. To assess the effect of PAF on IL-1 beta synthesis, THP-1 cell pellet proteins were separated by SDS-PAGE, blotted, and immunostained to detect IL-1 beta. Immunostaining revealed that PAF increases intracellular IL-1 beta precursor and that the combination of PAF and LPS increases IL-1 beta precursor synergistically. PAF increases IL-1 beta release mainly by increasing IL-1 beta synthesis.
Insights
Platelet-activating factor (PAF) stimulates interleukin-1 (IL-1) release from monocytes by increasing IL-1 synthesis. This mechanism is crucial for understanding the long-term effects of PAF, a lipid with a short half-life.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Platelet-activating factor (PAF) is a short-lived lipid mediator with potential long-term effects.
- PAF stimulates the release of cytokines, such as interleukin-1 (IL-1), from human monocytes.
- Understanding the mechanism of PAF-induced cytokine release is crucial for elucidating its biological roles.
Purpose of the Study:
- To investigate the mechanism by which PAF stimulates IL-1 release from human monocytic cells.
- To examine the role of IL-1 synthesis in PAF-mediated IL-1 release.
- To explore the synergistic effects of PAF and lipopolysaccharide (LPS) on IL-1 production.
Main Methods:
- Utilized the THP-1 human monocytic leukemia cell line.
- Measured IL-1 beta activity in cell supernatants.
- Assessed intracellular IL-1 beta precursor levels using SDS-PAGE, blotting, and immunostaining.
Main Results:
- PAF stimulated IL-1 beta release from THP-1 cells in a multiphasic dose-dependent manner.
- Combined treatment with PAF and LPS exhibited synergistic effects on IL-1 activity release.
- PAF was found to increase intracellular IL-1 beta precursor, indicating enhanced synthesis.
- Synergistic increase in IL-1 beta precursor was observed with combined PAF and LPS treatment.
Conclusions:
- PAF enhances IL-1 beta release primarily by increasing its synthesis.
- The THP-1 cell line serves as a valid model for studying PAF-induced IL-1 release.
- Synergistic interaction between PAF and LPS amplifies IL-1 production, suggesting complex regulatory mechanisms.